COVID-19 patients struggle to get highly touted yet elusive antibody treatments

Monoclonal antibody treatment is now available to COVID-19 patients, but only about 30% of the delivered doses have been administered.

Source: Los Angeles Times - Science - January 21, 2021 Category: Science Authors: JoNel Aleccia Source Type: news